For the first time, a team of experts from the Technical University of Munich (TUM), RWTH Aachen University, and the German ...

Bowel cancer risk is influenced by several overlapping factors including age, weight and inflammation. This study is early stage biology, but it strengthens the idea that long term gut health is ...

Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

A mere 10 minutes of daily physical activity could potentially safeguard the body from cancer. Recent research has revealed ...

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

Colorectal cancer is one of the deadliest cancers in the US — nearly 53,000 Americans are expected to die of it this year. Experts say you can reduce your risk of developing this “silent killer” ...

The incidence of early-onset colorectal cancer has been increasing worldwide, a trend that has coincided with growing intake ...

The British Society of Gastroenterology (BSG) has published new guidelines on colorectal cancer surveillance for patients with inflammatory bowel disease (IBD). Published in the BMJ journal Gut, the ...

One large study found that more advanced cases of colorectal cancer had a higher likelihood of returning. For example, if participants had stage 3 colon cancer, almost 25 percent experienced a ...

Biologist Eduard Batlle used to spend his weekends at his parents’ confectionery. Now he’s one of the six inventors of ...